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Introduction:  This  study  investigates  the  relative  inﬂuence  of  the  regional  availability  of
health  care  resources  (measured  by physician  densities,  number  of health  care  centers)  on
health  care  quality  (measured  by delay  in  diagnosis),  based  on  data  for the  rare disease
Marfan  Syndrome.
Methods:  Administrative  data from  389 patients  with  Marfan  Syndrome  were  analyzed.
Logistic  regression  models  were  applied  for  a dichotomous  comparison  of  the  dependent
variable  ‘time  to diagnosis’  with  the classiﬁcations  ‘immediate’  and  ‘late’  diagnosis.  Physi-
cian densities  of  cardiologists/angiologists,  ophthalmologists,  orthopedists,  and  GPs,  as  well
as  distance  to medical  health  care  centers  and  sociodemographic  information  were  entered
into  the  models.
Results: The  results  showed  that the  relationship  between  physician  densities  and  prob-
ability  of immediate  diagnosis  of  Marfan  Syndrome  is negative  linear,  and  quadratic  for
cardiologists/angiologists.  This  effect was  signiﬁcant  with  respect  to  density  of cardiolo-
gists/angiologists  (p  =  0.0097).  Distance  to  medical  health  care  centers  was  not  a predictor
of an  immediate  diagnosis.
Conclusion:  Marfan  Syndrome  faces  signiﬁcant  problems  of  quality  of  health  care,  as
although the requisite  quantity  of  health  care  resources  is  available,  this  does  not  affect
delay  in diagnosis.  Information  technology  might  foster  valuable  networking  among  physi-
cians treating  such  cases  along  with  holistic  assessment  of  symptoms  as  they  occur.
 . Introduction
In many health care systems it is generally assumed that
ncreasing health resources (i.e. higher physician densities,
ore health care centers) is associated with an increased
evel of health care quality for the population, and that this
s due to better accessibility [1–5]. The concept of health
are quality could be deﬁned in two ways, as measurement
f quality of outcomes (e.g. mortality, health status) [1,6–8]
r as measurement of quality of processes (e.g. short time
etween the onset of symptoms and the ﬁnal diagnosis of
∗ Correspondence address. Hamburg Center for Health Economics, Uni-
ersity of Hamburg, Esplanade 36, 20354 Hamburg, Germany.
E-mail address: Kathrin.Roll@wiso.uni-hamburg.de
168-8510 © 2012 Elsevier Ireland Ltd.  
oi:10.1016/j.healthpol.2012.02.003
Open access under CC BY-NC-ND license. © 2012 Elsevier Ireland Ltd. 
a disease) [9–12]. The assumption that more physicians or
a higher number of health care centers will induce better
health care quality complies with conventional wisdom.
Increasing the amount of health services is thus welcomed
in almost every country, and is seen as an important con-
tribution to the population’s health care. Of course this
assumption is dependent on the existing quality of health
care in a country. In developing countries it is indubitable
true that a greater provision of resources is associated with
better health care.
However, a second, smaller strand of literature sup-
ports the notion that this conventional wisdom is not
Open access under CC BY-NC-ND license.sustainable. Authors in this strand argue that socioeco-
nomic resources [7] or improvements in environmental
conditions [13] make a more signiﬁcant contribution to
health outcomes than the level of health care resources
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available. To date there is no clearly established relation-
ship between health care resources and health care quality.
The empirical ﬁndings in this controversy are derived from
studies of high-prevalence diseases – e.g. cancer – or of
infant mortality [6–8]. Given this background it would
be interesting to investigate the link between health care
resources and health care quality for the research ﬁeld of
rare diseases. Most rare diseases face the problem of delay
in diagnosis due to their rarity in a community and the lack
of ‘gold standards’. Therefore the time it takes to receive
a correct diagnosis of a rare disease could serve as an
indicator for the quality of a health care system. The inves-
tigation of the relationship between health care resources
and health care quality in this study is based on analysis of
the rare disease Marfan Syndrome.
Marfan Syndrome is a rare autosomal dominant dis-
ease of the connective tissue. The usually cited prevalence
is 2–3/10,000 inhabitants [14]. Marfan Syndrome leads
to fragmentation and disorganization of the elastic ﬁber.
This results in variable manifestations of its characteris-
tic features, e.g. progressive aortic dilatation associated
with aortic valve incompetence, mitral valve prolapse and
incompetence, lens dislocation and myopia, and a tall and
thin body with long limbs, arachnodactyly, pectus deformi-
ties, and scoliosis. Reported long-term outcomes of Marfan
Syndrome are aortic dissection, aortic regurgitation, con-
gestive heart failure, cardiovascular surgery, and death
[15–20].
Successful treatment of Marfan Syndrome relies solely
on pharmacological therapies. The treatment of choice is
medication with beta-adrenergic blocking and calcium-
channel blocking drugs to prevent aortic stiffness which
might lead to further need for surgical intervention. Addi-
tionally, physiotherapy is applied for the prevention of
further deformations of the locomotor system, in partic-
ular the spinal column [20–22].  For the reason that no
speciﬁc treatment of Marfan Syndrome exists, medication
and physiotherapy serve purely as treatments of symptoms
occurring with the affected organ systems. An accurate
diagnosis is mandatory to obtain proper counseling and
care of individuals with Marfan Syndrome, and early diag-
nosis can prolong life expectancy and reduce disability
prior to the development of e.g. aortic aneurysmal diseases
[23,24]. Still, Marfan Syndrome often poses a diagnostic and
therapeutic challenge. Because of its rarity and the mani-
festations in several organ systems, the correct diagnosis
is often delayed. As a result, many patients spend years
seeking a diagnosis. Early diagnosis could also prevent
the high cost which might arise from additional expenses
on non-purposeful treatments of Marfan Syndrome or the
treatment of differential diagnosis. Furthermore, an early
diagnosis offers the possibility to tailor the treatment to
individual manifestations in the afﬂicted organ system. As
other studies have demonstrated, higher physician den-
sity and shorter distances to a health care center offer
a greater availability of health care resources, which has
been associated with increased utilization of health ser-
vices (see a review by Léonard, Stordeur, and Roberfroid)
[25–27]. The question to be addressed in this paper is:
does the availability of health care resources for outpatient
care (measured by physician density) and inpatient care (2012) 119– 127
(measured by health care centers) in the regional surround-
ing of patients with initial symptoms of Marfan Syndrome
present an improvement of the outcome ‘delay in diagno-
sis’? The term ‘delay in diagnosis’ is deﬁned as the time to
diagnosis between the ﬁrst occurring symptom and the ini-
tial diagnosis of Marfan Syndrome. Physician densities and
the distance to a health care center—deﬁned in the follow-
ing as health care structures—might present an inﬂuencing
factor for the early detection of the ﬁrst typical symptoms
of Marfan Syndrome.
2. Materials and methods
To study the time span between the onset of the rare dis-
ease and the ﬁrst diagnosis of Marfan Syndrome, data on
outpatient and inpatient visits, pharmaceutical consump-
tion, and cost to the sickness fund were collected from the
Techniker Krankenkasse (TK), a nationwide German sick-
ness fund with more than 7.6 million insures in 2011. Data
were obtained for patients with an initial diagnosis for Mar-
fan Syndrome between 2004 and 2009.
To be included in the study, insurers had to be continu-
ously enrolled in the sickness fund for at least three years
before the appearance of a diagnosis of ‘Q87.4’, according
to the International Classiﬁcation of Diseases 10 (ICD-10).
After the ﬁrst occurrence of a diagnosis for ‘Q87.4’ in the
data, the patient was  considered to be diagnosed for Marfan
Syndrome. In the case of an outpatient diagnosis, a sec-
ond diagnosis of ‘Q87.4’ within 6 months was  required to
validate the initial diagnosis [28]. Persons were classiﬁed
into immediately diagnosed, meaning that the date of the
ﬁrst symptom is the date of the diagnosis (time to diagno-
sis [TtD] = 0 days: ‘immediate diagnosis’), and persons who
waited longer for the ﬁrst diagnosis of Marfan Syndrome
(TtD > 0 days: ‘late diagnosis’).
To approximate the onset of disease, outpatient and
inpatient data before time of diagnosis were screened
for symptoms commonly associated with Marfan Syn-
drome. Symptoms for Marfan Syndrome were selected
by screening medical studies about Marfan Syndrome
[15,17,18,20,23,24,29–31] and from medical expert opin-
ion. As a result, fourteen symptoms were identiﬁed:
‘E34.4’ constitutional tall stature, ‘H27’ other disorders of
lens, ‘H52.2’ astigmatism, ‘I34’ ﬂoppy mitral valve syn-
drome (excludes: Marfan syndrome), ‘I35’ nonrheumatic
aortic valve disorders, ‘I38’ endocarditis, ‘I71’ aortic
aneurysm and dissection, ‘J93’ pneumothorax, ‘M21.2’
ﬂat foot, ‘M24.7’ protrusio acetabula, ‘M41’ scoliosis,
‘Q38.5’ congenital malformations of palate, ‘Q67.5’ con-
genital deformity of spine, and ‘Q67.6’ pectus excavatum.
If the insurer had one of the fourteen ICD-10 diag-
noses commonly associated with Marfan Syndrome, it
was  assumed that Marfan Syndrome was present but
undiagnosed.
Insurers who changed their postcode between the
observation period were excluded, as were those who had
more than one postcode, as it could be assumed that they
had more than one residency and non-time-consistency of
residence would impede the measurement of the inﬂu-
ence of regional health care structures. The postcode in
Germany is usually 5-digit. Against the background of data
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rotection the postcode was only available as 3-digit post-
ode in the administrative data. In small-area variation
tudies, i.e. deﬁning areas as aggregates of postcodes, the
se of aggregated postcodes regions (3-digit) around the
atient’s residence that are in a one hour to one and a half
our traveling distance is recommended when measuring
he impact of health care structures on delay in diagnosis
28,32].
To explore the relative impact of different types of
roviders, services, and global indicators of health care
ccessibility, several measures of geographic access were
onstructed that may  be relevant for Marfan Syndrome
iagnosis.
To measure outpatient health care structures, physi-
ian density served as an indicator for the availability of
nd access to outpatient services, as proposed by Léonard
t al. [25]. Data on the density of GPs in the postcode
rea (3-digit) of the insurers per square kilometer were
ollected, because it was assumed that patients with
arfan Syndrome would contact them due to the het-
rogeneous disease pattern and the simultaneous effects
n several organ systems, before being referred to the
pecialist. Moreover, it was hypothesized that densi-
ies of cardiologists/angiologists, ophthalmologists, and
rthopedists—since these specialists may  be considered
y reason of their specialty to be most likely to come
nto early contact with the initial symptoms for Marfan
yndrome—would have an impact on delay in diagno-
is [33]. Information relating to the sizes of the postcode
reas and the number of physicians in them was  provided
y the Federal Ofﬁce for Building and Regional Planning
nd the Federal Association of Health Insurance Physicians
espectively. A high density of general practitioners (GP) or
pecialists for the various symptoms of Marfan Syndrome is
n indicator that access to medical knowledge might exist
n the area of residence of the patient [26,34].
Accordingly, regional health care structures in the inpa-
ient sector (e.g. a hospital specialized in cardiology or a
linic specialized in the treatment of Marfan Syndrome)
ituated within the postcode area of the affected might
nﬂuence the time until the ﬁrst diagnosis is made.
To measure the availability of inpatient health care,
oogle Maps was used to calculate the distance in kilo-
eters from the postcode area of the insurer to the nearest
reatment facility which is relevant for the treatment of
arfan Syndrome. Academic medical centers (AMC) (1),
ardiology centers (2), hospital units specializing in Marfan
yndrome [35] (3), ophthalmic hospitals (4), and institutes
or human genetics (5) were considered as relevant treat-
ent facilities and were deﬁned as health care centers.
In addition, we controlled for age and gender, and used
he number of visits to physicians during the 3 months
efore the ﬁrst appearance of symptoms of Marfan Syn-
rome as a proxy for the level of demand for health
ervices by the insurer before the onset of Marfan Syn-
rome. The area of residence of the insurer was classiﬁed
nto two regional types: (1) urban regions with more than
00 inhabitants/km2, (2) rural regions with less than 300
nhabitants/km2. We  also controlled for comorbidities 6
onths before the ﬁrst symptoms of Marfan Syndrome
ppeared according to the Elixhauser comorbidity index (2012) 119– 127 121
[36,37].  To avoid overﬁtting or lack of convergence by the
thirty variables in the dataset, the modiﬁed version of the
Elixhauser comorbidity index by van Walraven et al. was
used, which weights each comorbidity according to the dis-
ease burden and results in a single numeric score [38].
Logistic regression models with the dependent variable
‘time to diagnosis’ (TtD) were then employed. As explained
above, TtD had the characteristics ‘immediate’ (TtD = 0) and
‘late’ (TtD > 0). Four regression models were created includ-
ing age (AGE), gender (GEN), the Elixhauser score (ELIX),
residence (RES), number of visits to physicians during the
3 months before the ﬁrst symptoms for Marfan Syndrome
appeared (PV), and distance to nearest health care center
(DIST).
To avoid high correlation among independent variables,
the cardiologist/angiologist density per 100 km2 in the 3-
digit postcode area was  included in regression model I
(DENS1), the ophthalmologist density per 100 km2 in the
3-digit postcode area for regression model II (DENS2), the
orthopedist density per 100 km2 in the 3-digit postcode
area in regression model III (DENS3), and the GP density per
100 km2 in the 3-digit postcode area for regression model
IV (DENS4). It was assumed that TtD is a function of:
TtD = f (AGE, GEN, DENSi, DIST, PV, RES).
Overall model ﬁt was assessed using the
Hosmer–Lemeshow goodness-of-ﬁt test to evaluate
model calibration. In this test, a large p-value indicates
that the model is performing well, i.e. that there is not
a large discrepancy between observed and expected
immediate or late diagnosis [39]. The Hosmer–Lemeshow
goodness-of-ﬁt test indicated that model I, model II,
model III, and model IV were well calibrated (Model I:
p = 0.7803; Model II: p = 0.9913; Model III: p = 0.8241;
Model IV: p = 0.7312). Collinearity was assessed using
variance inﬂation factors (VIF). In the logistic models, none
of the VIF values were greater than 1.20, suggesting that
collinearity was not a signiﬁcant problem in these models.
3. Results
During our observation period (2004–2009) there were
1248 insurers who had the conﬁrmed ICD-10 diagnosis
for Marfan Syndrome ‘Q87.4’. The criterion of continuous
enrollment of at least three years before the initial diagno-
sis of Marfan Syndrome was fulﬁlled for 447 insurers. To
illustrate the inﬂuence of geographical health care struc-
tures, insurers who changed their residence were excluded.
As a result, 389 insurers with Marfan Syndrome fulﬁlled the
inclusion criteria.
Table 1 displays the descriptive characteristics of the
study sample. Descriptive statistics reveal that 174 insur-
ers (44.7%) experienced an immediate diagnosis (TtD = 0) of
Marfan Syndrome and the remaining 215 insurers (55.3%)
were diagnosed after a time period greater than 0 days,
with an average time to diagnosis of 607 days, a median of
641 days, and a maximum of 1095 days. The density of car-
diologists/angiologists was  higher for insurees with a late
diagnosis than for insurers with an immediate diagnosis
(4.48 vs. 3.43, p = 0.062). The same effect could be found for
122 K. Roll / Health Policy 105 (2012) 119– 127
Table 1
Baseline characteristics of the study population.
Baseline characteristics
Marfan Syndrome diagnosis
Immediate (=0 days) [Mean
(SD)] or % n = 174
Late (>0 days) [Mean
(SD)] or % n = 215
P-Value
Outpatient variables
Cardiologists/Angiologists density per km2 in the
3-digit postal code area
3.43 (5.33) 4.48 (5.60) 0.0619
Ophthalmologists density per km2 in the 3-digit
postal code area
8.38 (13.09) 11.17 (15.33) 0.0577
Orthopedists density per km2 in the 3-digit postal
code area
8.85 (14.07) 11.68 (16.17) 0.0705
GP  density per km2 in the 3-digit postal code area 71.09 (108.60) 93.21 (128.11) 0.0710
Inpatient variable
Distance to nearest health care center in km 10.78 (11.85) 10.13 (12.61) 0.6065
Control  variables
Age in years 23.67 (14.07) 24.77 (16.01) 0.4795
Elixhauser Score 2.33 (4.53) 6.15 (7.7) 0.0001
Number of physicians visits 3 months before ﬁrst
symptoms for Marfan Syndrome
11.78 (25.95) 19.57 (32.87) 0.0112
Gender  0.5159
Male  58.62 61.86
Female 41.38 38.14
8 
2 
p = 0.4314; Model IV: p = 0.4763). Distance is therefore not
an indicator for the likelihood of experiencing an immedi-
ate diagnosis.
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Physicians density  per  km²  in  the 3-digit  postal code  are a
Cardiologists/Ang iologists
Opht halmolo gists
Orthoped ists
GPResidence
Urban regions 48.2
Rural regions 51.7
ophthalmologist density (11.17 vs. 8.38, p = 0.058). Comor-
bidities differed between the data sample with a late
diagnosis and that with an immediate diagnosis. The lat-
ter showed an Elixhauser score of 2.33 (range: −5 to 17)
whereas the average insurer with a late diagnosis of Mar-
fan Syndrome had a value of 6.15 (p < 0.0001) (range: −10 to
41). The number of visits to physicians differed between the
immediate and late-diagnosed insurers. Late-diagnosed
insurers showed more visits during the 3-month period
before the ﬁrst symptom for Marfan Syndrome appeared
compared to immediately diagnosed insurers (19.57 vs.
11.78, p = 0.011) (Table 1).
3.1. Impact of regional health care structures on delay in
diagnosis
As each physician density measure was entered in one
of the four models the coefﬁcients were not signiﬁcantly
different (Model I: –0.1988; Model II: –0.0323; Model III:
–0.0321; Model IV: –0.0041). The signs of the density mea-
sures indicate that an increased availability of specialists
in the regional surroundings of the insurer decreases the
probability of an immediate diagnosis (Model I: p = 0.0028;
Model III: p = 0.0968; Model IV: p = 0.0992). This effect was
not signiﬁcant for GPs (Model II: p = 0.1031).
We  also tested non-linear effects of the density mea-
sures, and the squared density measures were additionally
entered in the four models. We  plotted the relationship
between each density measure and the probability of an
immediate diagnosis. Apparently, an increasing density of
the different types of physicians had an opposing effect on
the probability of immediate diagnosis, whereas the sign
of the squared physician density measures indicated that
a further increase of the physician density in the post-
code area of an insurer with Marfan Syndrome increased0.1388
55.81
44.19
the probability of an immediate diagnosis. This trend was
conﬁrmed for all specialist density measures used but was
only signiﬁcant for the density of cardiologists/angiologists
(p = 0.0097) (Fig. 1).
The inpatient variable ‘distance to health care center’
did not make a signiﬁcant contribution in all four mod-
els (Model I: p = 0.2414; Model II: p = 0.467; Model III:160140120100806040200
Distribuon of data: Physicians per km²  in thedensity 3-d igit  postal areacode
Fig. 1. Probability of an immediate diagnosis according to physicians den-
sity per km2 in the 3-digit postcode area.
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Table 2
Results of logistic regression models.
Time to diagnosis (Immediate vs. Late)
Model I Model II Model III Model IV
Variables Estimate P-value Odds ratioa Estimate P-value Odds ratio Estimate P-value Odds ratio Estimate P-value Odds ratio
Intercept 0.7326 0.0195 ** 0.4787 0.1051 0.4758 0.1042 0.4948 0.1002
Outpatient Variables
Cardiologists/Angiologists density per km2 in the
3-digit postal code
−0.1988 0.0028 ** 0.82
Cardiologists/Angiologists
density*Cardiologists/Angiologists density
0.0079 0.0097 **
Ophthalmologists density per km2 in the 3-digit
postal code area
−0.0323 0.1031 0.97
Ophthalmologists density*Ophthalmologists density 0.0002 0.3873
Orthopedists density per km2 in the 3-digit postal
code area
−0.0321 0.0968 * 0.97
Orthopedists density*Orthopedists density 0.0002 0.3435
GP  density per km2 in the 3-digit postal code area −0.0041 0.0992 * 1.00
GP  density per km2*GP density per km2 0.0000 0.3346
Inpatient variable
Distance to nearest health care center in km −0.0118 0.2414 1.00 −0.0072 0.467 0.99 −0.0078 0.4314 0.99 −0.0070 0.4763 0.99
Control Variables
Age in years 0.0085 0.2731 1.00 0.0088 0.2551 1.01 0.0093 0.23 1.01 0.0088 0.2579 1.01
Elixhauser Score −0.1225 <0.0001 *** 0.89 −0.1174 <0.0001 *** 0.89 −0.1183 <0.0001 *** 0.89 −0.1182 <0.0001 *** 0.89
Number of physicians visits 3 months before ﬁrst
symptoms for Marfan Syndrome
−0.0131 0.0027 ** 0.99 −0.0122 0.0049** 1.00 −0.0122 0.0048 ** 1.00 −0.0121 0.0052 ** 1.00
Gender
Male  Reference Reference Reference Reference
Female 0.1791 0.4296 1.20 0.1785 0.4280 1.20 0.1703 0.4495 1.19 0.1737 0.4404 1.19
Residence
Urban  regions Reference Reference Reference Reference
Rural  regions −0.1618 0.2776 0.72 −0.0757 0.6039 0.86 −0.0617 0.6618 0.88 −0.0698 0.6289 0.8
* p < 0.1.
** p < 0.05.
*** p < .001.
a Odds ratios represent odds of a given immediate diagnosis (of 0 days) and a given late diagnosis (more than 0 days). Cl indicates conﬁdence interval.
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Among the control variables included, the strongest sig-
niﬁcant predictor of a late diagnosis in models I–IV was
the Elixhauser score value. Speciﬁcally, a high Elixhauser
score decreased the chance of an immediate diagnosis by a
factor of 0.89 (Model I–Model IV: p = < 0.0001). One other
predictor in the control variables which made a signiﬁ-
cant contribution to the models was the number of visits to
physicians during the 3 months before the ﬁrst symptom of
Marfan Syndrome appeared (Model I: p = 0.0027; Model II:
p = 0.0049; Model III: p = 0.0048; Model IV: p = 0.0052). The
odds of an insurer indicating that s/he had an immediate
diagnosis are decreased by a factor of 0.99 (Model I) and
1.00 (Models II–IV) respectively if s/he had more visits in
the time period before the ﬁrst symptom (Table 2).
3.2. Sensitivity analysis
The robustness of the ﬁndings was tested by performing
sensitivity analyses for the four models. First, the den-
sity per 100,000 inhabitants for cardiologists/angiologists,
ophthalmologists, orthopedists, and GPs in the models
were included instead of density per km2; however, the
results were unaffected. Second, the ﬁve models were
re-estimated with each single distance in km for AMCs,
cardiology centers, hospital units specializing in Marfan
Syndrome, ophthalmic hospitals, and institutes for human
genetics, instead of the aggregated variable ‘distance to
nearest health care center’. However, the results of the
regression models with each of the ﬁve distance variables
instead of the single aggregated one changed, and were
no longer signiﬁcant. Third, the models were re-estimated
with the ‘time to diagnosis’ between the appearance
of the second distinctive symptom and the initial diag-
nosis instead of the ﬁrst symptom; results remained
unaffected. Fourth, the models were re-estimated with
‘immediate diagnosis’ deﬁned by less than 90 days between
the ﬁrst symptom and the initial diagnosis. But the
results remain robustly. Fifth, the density measure of
internists instead of cardiologists/angiologists was  tested
in an extra model, but this was not signiﬁcant. Sixth, a
binary variable ‘residence proximity to AMC’ was con-
structed and included in the four models, but this did
not have an effect on the probability of an immediate
diagnosis.
4. Discussion
In this paper the association between the impact of
geographic health care resources for outpatient care and
inpatient care on the delay in diagnosis of Marfan Syn-
drome was evaluated using logistic regression models.
Only a few studies have investigated the link between
health care resources and health outcomes in the form of
quality of outcomes (e.g. mortality, health status) [1,6–8]
or as measurement of quality of processes (e.g. short time
between the onset of symptoms and the ﬁnal diagnosis of
a disease) [9–12]. They have arrived at different conclu-
sions [2–8,13]. This study followed a more reﬁned approach
than previous studies which focused on the incidence of
non-rare diseases, by testing the postulate of availability of
health resources and its association with delay in diagnosis (2012) 119– 127
by using outpatient and inpatient variables as elaborations
of regional geographical health care structures. Moreover,
the analysis was  carried out with administrative data. Star-
gardt and Schreyögg discussed this reﬁned approach in
detail [28].
Related studies on delay in diagnosis on health out-
comes have focused on the socioeconomic characteristics
of the patients or physicians, the surveillance source of
diagnosis (inpatient or outpatient), and the inﬂuence on
delay in diagnosis of non-rare diseases [10,12,40,41].  This
study used physician density as a proxy for outpatient
health care resource and distance to nearest health care
center as a proxy for inpatient health care resource. So far,
only a few studies have examined the relationship between
physician density [25,27] or distance to medical health care
centers [34,42–46] and the use of health care services for
non-rare diseases. Some recent studies have analyzed the
utilization rates for speciﬁc conditions (e.g. breast cancer)
depending on geographical factors [47–49],  but these stud-
ies only focused on the geographical utilization of health
care services without considering the inﬂuence of geo-
graphical health care structures on health care outcomes.
Only one study so far has analyzed the inﬂuence of geo-
graphical factors on the early diagnosis of autism as a health
care outcome [26].
4.1. Impact of regional health care structures on time to
diagnosis
The results showed evidence that the relationship
between physician densities in the postal code area and
the probability of an immediate diagnosis of Marfan
Syndrome, rather than being linear, is quadratic for car-
diologists/angiologists and negative linear otherwise. This
result might be the consequence of several reasons. On
the one hand, the involvement of more physicians—who
are available precisely because of the high density—might
delay immediate diagnosis, as German physicians often
work on a stand-alone basis. There is usually neither an
institutionalized nor a systematic exchange of informa-
tion, especially between in- and outpatient care providers.
This asymmetry of information among physicians might
therefore hinder immediate diagnosis of Marfan Syndrome,
a disease with high complexity due to its syndromes in
multiple organ systems. Furthermore, selection among
physicians by the patient might be less efﬁcient where the
supply is more extensive.
On the other hand, an increased number of physicians
allows a specialization in smaller treatment areas and so
may  also likely contribute to a faster diagnosis. There-
fore the negative effect of asymmetric information on an
immediate diagnosis becomes compensated by the special-
ization of physicians when the physician density is further
increased (Fig. 1). It is assumed that the availability of more
physicians might facilitate more frequent visits and more
frequent changes of physicians by the patient who is look-
ing for a correct diagnosis. The treating physician might
also evince lower motivation in ﬁnding the correct diag-
nosis where s/he is aware that colleagues failed to ﬁnd
a diagnosis—a pattern of behavior known as ‘organized
irresponsibility’ [50]. This may  result in a further delay
licy 105
i
A
w
c
c
s
i
l
a
p
f
n
t
t
n
o
m
g
a
d
l
t
i
d
s
f
K
h
a
t
e
c
t
a
c
o
S
r
f
r
i
t
a
c
s
i
T
o
s
a
d
f
b
c
b
M
t
r
qK. Roll / Health Po
n diagnosis as different types of physicians get involved.
 long-term and sustained physician–patient relationship
ould be more likely to promote the effectiveness of health
are outcomes, in this case delay in diagnosis [51]. The
urvilinear trend in the study was observed for all types of
pecialists except for GPs. This might be because a further
ncrease of GP density in, for example, an urban region is
inked with a further increase in the density of specialists
s well. Where the patients have the choice, they might
refer to consult specialists with their speciﬁc symptoms
or Marfan Syndrome while GPs would be consulted less.
The delay in diagnosis might also be the result of cog-
itive aspects of overconﬁdence in medical diagnosis by
he physician. Other studies have found that physicians
end not to question the correctness of their own  diag-
oses. Diagnostic errors rarely occur because of a lack
f knowledge about a rare disease per se: more com-
only, diagnostic errors are based on cognitive errors in
athering the right information about the patient, such
s putting together heterogeneous information about a
isease [52,53]. This negligence could be particularly prob-
ematic for the diagnosis of Marfan Syndrome.
A signiﬁcant contribution could not be found regarding
he inﬂuence of health care centers on the likelihood of an
mmediate diagnosis. This is not surprising as Marfan Syn-
rome was almost exclusively diagnosed in an outpatient
etting (98%). Other studies, however, have presented dif-
erent results regarding the distances to health care centers.
alkbrenner et al. [26], analyzing geographical access to
ealth services and its inﬂuence on the time to diagnosis for
utism, found that diagnosis at a younger age characterized
hose areas which are proximal to medical schools. How-
ver, these results were found in the context of the speciﬁc
haracteristics of autism [26]. In the present study, the con-
rol variables for patient characteristics such as age, gender,
nd residence did not show a signiﬁcant effect on the out-
ome ‘time to diagnosis’. The results indicating the lack
f inﬂuence of age is due to the characteristics of Marfan
yndrome: there is widespread phenotypic variability with
egard to age of onset and degree of manifestation of Mar-
an Syndrome in the various organ systems [15]. Reverse
esults were found for the comorbidities of the insurers: an
ncreasing number of comorbidities signiﬁcantly decreased
he chance of an immediate diagnosis by a factor of 0.89 for
ll four models. This suggests that the existence of more
omorbidities complicates the diagnosis, because the ﬁrst
ymptoms for Marfan Syndrome might not be detected
mmediately by the physician if other diseases are present.
he same effect could be found for the variable ‘number
f visits to physicians during 3 months before the ﬁrst
ymptoms for Marfan Syndrome’. The results indicated that
n increased number of visits to physicians signiﬁcantly
ecreased the probability of an immediate diagnosis in all
our models. With increased numbers of visits to physicians
efore the onset of Marfan Syndrome, the speciﬁc medical
onditions of the patients may  not receive enough attention
y the physician, which might result in delayed diagnosis of
arfan Syndrome. This result contributes to the initial pos-
ulate and suggests that it is not the quantity of health care
esources—i.e. the number of visits to physicians—but the
uality of health care which is crucial for health outcomes. (2012) 119– 127 125
Several of the measures used were not associated with
an increase in the probability of an immediate diagnosis.
It is possible that insurers with Marfan Syndrome were
highly motivated to obtain a diagnosis regardless of geo-
graphic barriers, and so the assumption that the affected
insurer visited the nearest physician or health care facil-
ity may  not hold [54]. Additional explanations include that
the diagnosis for Marfan Syndrome was  inﬂuenced more
by interpersonal networks than geographical locations. Liu
et al. [55] and Kalkbrenner et al. [26] point out that spatially
localized person-to-person contacts are especially impor-
tant in diffusing information about symptoms, health care
services, and access to information. In the speciﬁc case
of rare diseases, a study by EURODIS found that 18% of
the diagnoses were based on the inﬂuence of non-health
professional sources (e.g. internet, family, friends, other
patients) [56].
4.2. Limitations
This study has several limitations. First, it was not possi-
ble to control for important socioeconomic characteristics
of the insurers; education, e.g., would have been a proxy
for the ability to assess the initial symptoms of Marfan
Syndrome or the ability to access information about the
disease via the Internet or other media channels. Second,
the study lacks information about the characteristics of the
treating physician, such as the exact location of the practice
or professional experience. Third, only health services that
were included in the administrative data were captured,
but information about whether the insurer made use of any
other health care services which are not provided by the
health insurance was missing. It may  also be possible that
insurers used complementary insurance plans that provide
alternative treatment methods that inﬂuenced the time to
diagnosis. Fourth, the mapping of physician densities as an
exposure measure for the availability of health care ser-
vices in the outpatient sector for Marfan Syndrome can be
thought of potential access to services, but it is not certain
that the insurer made use of these services. Other studies,
however, have demonstrated that densities measures are
strongly related to health care utilization and do capture
the access to health care that is presented by the relation-
ship between the patient’s need and the volume of services
[25,57–59].
5. Conclusion
In general the results demonstrate that the quantity of
physicians and the nearest available health care center do
not play an important role in determining the probabil-
ity of an immediate diagnosis for Marfan Syndrome. The
underlying assumption is that the adoption of a structured
approach is mandatory for the diagnosis of rare diseases,
as well as for other diseases that are complex to diag-
nose.
Building on the initial postulate that increasing health
resources should be associated with increased quality of
health care for the population, this study contributes to
the discussion by adding empirical ﬁndings for rare dis-
eases, speciﬁcally the case of Marfan Syndrome. The results
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clearly show that signiﬁcant problems with the quality
of health care exist for Marfan Syndrome. A high level
of health care resources in terms of quantity—e.g. physi-
cian density, health care centers, number of physician
contacts—may not necessarily have a positive effect on
health outcomes in terms of delay in diagnosis.
This study raises concerns that an unspeciﬁc provision
of health care resources leads to delayed and inadequate
treatment of patients with Marfan Syndrome, which may
result in reduced health outcomes. Enhanced networking
among the physicians across sectors is important for foster-
ing more seamless processes for the treatment of patients
with rare diseases. This consideration is also in line with
the draft law of the German Ministry of Health [60]. This act
advocates that health care for rare and highly complex dis-
eases should be treated in multidisciplinary teams across
sectors.
Exchange of information and increased communica-
tion among physicians about the treatment history of each
patient might foster the holistic assessment of symptoms
being presented for rare diseases. Encouraging the use of
health information technology (HIT) (e.g. electronic medi-
cal records) may  be one option to implement this. A study
by Schoen et al., inter alia about the use of HIT among pri-
mary care physicians in eleven countries, indicated that the
functional capacity of electronic medical records is lowest
in Germany.
In other countries that have already adopted HIT it is
apparent that this was instrumental in improving health
outcomes and avoiding duplication [61,62]. The poten-
tial value of HIT is also demonstrated by the Veterans
Health Administration (VHA) in the USA, which had imple-
mented HIT in all its facilities by 1999 [63,64]. HIT has
been shown to improve the coordination of care between
local and referral providers and to improve quality by
increasing adherence to guidelines, enhancing disease
surveillance, and decreasing medication errors (see a
review by Chaudhry et al.) [65].
On the basis of the present study, further research is
needed to analyze the appropriate measures to enhance
the networking of physicians.
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